Key result
Erythropoietin stimulates hypoxic CSN activity below ~0.5 IU/ml but inhibits it at higher concentrations.
Why the study?
EPO regulates respiration through brainstem centers, but its dose-dependent impact on carotid body responses to hypoxia and hypercapnia remained to be investigated.
Does erythropoietin modulate carotid sinus nerve activity in response to hypoxia and hypercapnia in adult male rats?
Does erythropoietin modulate carotid sinus nerve activity in response to hypoxia and hypercapnia in adult male rats?
Erythropoietin exhibits a dose-dependent dual effect on carotid body chemoreception, stimulating the hypoxic response at low doses and inhibiting it at high doses via nitric oxide production.
Answers are grounded in this paper and cite their sources.
EPO's biphasic chemoreflex effects warrant clinical caution at high doses; hypothesis-generating in rats and requires human validation.
Erythropoietin (EPO) regulates respiration under conditions of normoxia and hypoxia through interaction with the respiratory centers of the brainstem. Here we investigate the dose-dependent impact of EPO in the CB response to hypoxia and hypercapnia. We show, in isolated “ en bloc ” carotid body (CB) preparations containing the carotid sinus nerve (CSN) from adult male Sprague Dawley rats, that EPO acts as a stimulator of CSN activity in response to hypoxia at concentrations below 0.5 IU/ml. Under hypercapnic conditions, EPO did not influence the CSN response. EPO concentrations above 0.5 IU/ml decreased the response of the CSN to both hypoxia and hypercapnia, reaching complete inhibition at 2 IU/ml. The inhibitory action of high-dose EPO on the CSN activity might result from an increase in nitric oxide (NO) production. Accordingly, CB preparations were incubated with 2 IU/ml EPO and the unspecific NO synthase inhibitor (L-NAME), or the neuronal-specific NO synthase inhibitor (7NI). Both NO inhibitors fully restored the CSN activity in response to hypoxia and hypercapnia in presence of EPO. Our results show that EPO activates the CB response to hypoxia when its concentration does not exceed the threshold at which NO inhibitors masks EPO’s action.
No takes yet. Share an insight, caveat, or question.
Arias‐Reyes et al. (2021) studied Normal physiology (carotid body chemoreception). Erythropoietin (EPO) vs. Control (0 IU/ml) was evaluated on Maximum carotid sinus nerve (CSN) activity under hypoxia (p=0.0007). Erythropoietin stimulated carotid sinus nerve activity in response to hypoxia at concentrations below 0.5 IU/ml, but inhibited the response to both hypoxia and hypercapnia at concentrations above 0.5 IU/ml.
Synapse has enriched 10 related papers. Consider them for comparative context: